A Novel Allogeneic Rituximab-Conjugated Gamma Delta T Cell Therapy for the Treatment of Relapsed/Refractory B-Cell Lymphoma.
Li HK, Wu TS, Kuo YC, Hsiao CW, Yang HP, Lee CY, Leng PJ, Chiang YJ, Cheng ZF, Yang SH, Lin YL, Chen LY, Chen CS, Chen YJ, Hsiao SC, Tang SW.
Li HK, et al. Among authors: cheng zf.
Cancers (Basel). 2023 Oct 4;15(19):4844. doi: 10.3390/cancers15194844.
Cancers (Basel). 2023.
PMID: 37835538
Free PMC article.